Akero Therapeutics, Inc.·4

Jun 3, 4:06 PM ET

Judy Chou 4

4 · Akero Therapeutics, Inc. · Filed Jun 3, 2022

Insider Transaction Report

Form 4
Period: 2022-06-02
Judy Chou
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-02+15,00015,000 total
    Exercise: $8.13Exp: 2032-06-01Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]This option shall vest in full upon the earlier of (i) June 2, 2023 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION